Plunkett Research Online: Biocure Technology

BIOCURE TECHNOLOGY (CURE:CNQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Biocure Technology Inc is a Canadian biopharmaceutical company. It is engaged in developing and commercializing several biopharmaceutical technologies relating to uses of recombinant and ranibizumab......



Biocure Technology
Ticker: CURE
Exchange: CNQ
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 630-3838
Fax: 888 241-5996
Address: 1055 West Hastings Street
Suite 300
Vancouver, BC V6E 2E9 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description

Ruben Verzosa CEO/Director/President
Nizar Bharmal CFO/Director
See More
Biocure Technology Inc is a Canadian biopharmaceutical company. It is engaged in developing and commercializing several biopharmaceutical technologies relating to uses of recombinant and ranibizumab......See More See More

Auditor: DALE MATHESON CARR-HILTON LABONTE LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2017 2016 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: